ask="77.00"
ask_size="300"
average_daily_volume="319105"
bid="76.00"
bid_size="100"
book_value="6.84"
change="-0.45"
change_from_200_day_moving_average="6.57"
change_from_50_day_moving_average="6.23"
change_from_52_week_high="-11.54"
change_From_52_week_low="43.22"
change_in_percent="-0.59%"
close="76.24"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="1.54"
ebitda="26.14M"
eps_estimate_current_year="4.12"
eps_estimate_next_quarter="1.59"
eps_estimate_next_year="4.56"
ex_dividend_date="N/A"
float_shares="9176000"
high="80.91"
high_52_weeks="87.78"
last_trade_date="3/1/2017"
last_trade_price="76.24"
last_trade_size="13385"
last_trade_time="4:00pm"
low="71.07"
low_52_weeks="33.02"
market_capitalization="1.18B"
moving_average_200_day="69.67"
moving_average_50_day="70.01"
name="Eagle Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="85.00"
open="77.18"
pe_ratio="49.64"
peg_ratio="1.26"
percent_change_from_200_day_moving_average="+9.43%"
percent_change_from_50_day_moving_average="+8.90%"
percent_change_from_52_week_high="-13.14%"
percent_change_from_52_week_low="+130.89%"
previous_close="76.69"
price_eps_estimate_current_year="18.50"
price_eps_Estimate_next_year="16.72"
price_per_book="11.22"
price_per_sales="9.36"
revenue="126.52M"
shares_outstanding="15435000"
short_ratio="7.53"
stock_exchange="NGM"
symbol="EGRX"
volume="609529"
weeks_range_52="33.02 - 87.78"
